217 related articles for article (PubMed ID: 17767353)
1. Prostaglandin receptor signaling in disease.
Matsuoka T; Narumiya S
ScientificWorldJournal; 2007 Sep; 7():1329-47. PubMed ID: 17767353
[TBL] [Abstract][Full Text] [Related]
2. Prostanoids receptors signaling in different diseases/cancers progression.
Yang Y; Tang LQ; Wei W
J Recept Signal Transduct Res; 2013; 33(1):14-27. PubMed ID: 23327583
[TBL] [Abstract][Full Text] [Related]
3. The roles of prostanoids in infection and sickness behaviors.
Matsuoka T; Narumiya S
J Infect Chemother; 2008 Aug; 14(4):270-8. PubMed ID: 18709530
[TBL] [Abstract][Full Text] [Related]
4. Function of prostanoid receptors: studies on knockout mice.
Kobayashi T; Narumiya S
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():557-73. PubMed ID: 12432943
[TBL] [Abstract][Full Text] [Related]
5. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S
Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928
[TBL] [Abstract][Full Text] [Related]
6. Prostanoids in immunity: roles revealed by mice deficient in their receptors.
Narumiya S
Life Sci; 2003 Dec; 74(2-3):391-5. PubMed ID: 14607267
[TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of prostanoid FP-, DP-, IP- and TP-receptors on the non-pregnant human myometrium.
Senior J; Sangha R; Baxter GS; Marshall K; Clayton JK
Br J Pharmacol; 1992 Sep; 107(1):215-21. PubMed ID: 1422574
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiological roles of the prostanoids in the cardiovascular system: studies using mice deficient in prostanoid receptors].
Hara A; Yuhki K; Fujino T; Narumiya S; Ushikubi F
Nihon Yakurigaku Zasshi; 2003 Nov; 122(5):384-90. PubMed ID: 14569157
[TBL] [Abstract][Full Text] [Related]
9. [Activation Mechanism of Prostanoid Receptors -X-ray Crystallography of EP3 Receptor].
Morimoto K
Yakugaku Zasshi; 2021; 141(4):473-479. PubMed ID: 33790113
[TBL] [Abstract][Full Text] [Related]
10. Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mouse studies.
Yuhki K; Kojima F; Kashiwagi H; Kawabe J; Fujino T; Narumiya S; Ushikubi F
Pharmacol Ther; 2011 Feb; 129(2):195-205. PubMed ID: 20920529
[TBL] [Abstract][Full Text] [Related]
11. Molecular and pharmacological characterization of zebrafish 'contractile' and 'inhibitory' prostanoid receptors.
Iwasaki R; Tsuge K; Morimoto K; Inazumi T; Kawahara O; Kawahara A; Tsuchiya S; Sugimoto Y
Biochem Biophys Res Commun; 2013 Aug; 438(2):353-8. PubMed ID: 23892039
[TBL] [Abstract][Full Text] [Related]
12. Prostanoid receptor assays.
Chen J; Woodward DF; Coleman RA; Jones RL; Lydford SJ
Curr Protoc Pharmacol; 2001 Nov; Chapter 4():Unit4.18. PubMed ID: 21959759
[TBL] [Abstract][Full Text] [Related]
13. Roles of prostanoids in colon carcinogenesis and their potential targeting for cancer chemoprevention.
Mutoh M; Takahashi M; Wakabayashi K
Curr Pharm Des; 2006; 12(19):2375-82. PubMed ID: 16842185
[TBL] [Abstract][Full Text] [Related]
14. Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2alpha on melanocyte dendricity.
Scott G; Leopardi S; Printup S; Malhi N; Seiberg M; Lapoint R
J Invest Dermatol; 2004 May; 122(5):1214-24. PubMed ID: 15140225
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandins in the kidney: developments since Y2K.
Nasrallah R; Clark J; Hébert RL
Clin Sci (Lond); 2007 Oct; 113(7):297-311. PubMed ID: 17760567
[TBL] [Abstract][Full Text] [Related]
16. Physiology and pathophysiology of prostanoid receptors.
Narumiya S
Proc Jpn Acad Ser B Phys Biol Sci; 2007 Dec; 83(9-10):296-319. PubMed ID: 24367153
[TBL] [Abstract][Full Text] [Related]
17. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
19. Prostanoid receptor heterogeneity through alternative mRNA splicing.
Pierce KL; Regan JW
Life Sci; 1998; 62(17-18):1479-83. PubMed ID: 9585122
[TBL] [Abstract][Full Text] [Related]
20. The vasoconstrictor activities of prostaglandin D
Guo T; Liu B; Zeng R; Lin R; Guo J; Yu G; Xu Y; Tan X; Xie K; Zhou Y
Eur J Pharmacol; 2023 Oct; 956():175963. PubMed ID: 37543159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
